Table 1. Baseline patient characteristics of included EUS-GE studies.
Author | Year | Study design | EUS-GE technique | Stent size, type | No. patients | Follow-up period (mons) | Mean age (years) | No. males (%) | No. benign obstructions | No. of malignant obstructions | Procedure time (min) | Technical success | Clinical success | Serious adverse events | Minor adverse events | No. of re-interventions | Newcastle-Ottawa Quality Assessment |
Ge et al. | 2019 | Single-center, retrospective comparator study | Direct (n = 24) | 15 × 10 mm CE-LAMS | 22 | – | 66.4 | 9 | 0 | 22 | – | 24/24 | 23/24 | 3/24 | 2/24 | 2/25 | 5.5 |
Kerdsirihair at et al. | 2018 | Multicenter, retrospective non-comparator study | Direct (n = 57) | 15 × 10 mm CE-LAMS | 57 | 6.5 | 65 | 28 | 9 | 48 | 39 | 53/57 | 51/57 | 1/57 | 1/57 | 8/53 | 6.5 |
Chen et al. (Direct) | 2018 | Multicenter, retrospective comparator study | Direct (n = 52) | 15 × 10 mm CE-LAMS and 15 × 10 mm NCE-LAMS | 52 | 3.8 | 62.9 | 22 | 18 | 34 | 35.7 | 49/52 | 48/52 | 1/52 | 2/52 | 3/52 | 7.0 |
Chen et al. (Balloon) | 2018 | Multicenter, retrospective comparator study | Balloon-assisted (n = 22) | 15 × 10 mm CE-LAMS and 15 × 10 mm NCE-LAMS | 22 | 3.8 | 63.3 | 11 | 7 | 15 | 89.9 | 20/22 | 20/22 | 0/22 | 2/22 | 4/22 | 7.0 |
Itoi et al. | 2016 | Single-center, prospective non-comparator study | PASS (n = 20) | 15 × 10 mm CE-LAMS | 20 | 3.3 | 10 | 0 | 20 | 25.5 | 18/20 | – | 1/20 | 1/20 | – | 5.0 | |
Tyberg et al. | 2016 | Multicenter, retrospective non-comparator study | Balloon-assisted (n = 13); Ultra-slim scope (n = 5); Nasobiliary drain (n = 3); Direct (n = 3); NOTES (n = 2) | 15 × 10 mm and 10 × 10 mm CE-LAMS | 26 | 1.8 | 66.2 | 11 | 9 | 17 | – | 24/26 | 22/26 | 3/26 | 2/26 | 1/26 | 6.0 |
CE-LAMS, cautery-enhanced lumen-apposing metal stent; NCE-LAMS, non-cautery-enhanced lumen-apposing metal stent; PASS, EUS-guided double-balloon-occluded gastrojejunostomy bypass.